Expanding Clinical Utilization of Checkpoint Inhibitors for Cancer Treatments Necessitates the Development of Predictive Models for Immunotherapy-Induced Pneumonitis
Expanding Clinical Utilization of Checkpoint Inhibitors for Cancer Treatments Necessitates the Development of Predictive Models for Immunotherapy-Induced Pneumonitis
Creators
Ivaylo B Mihaylov
Publication Details
Biomedical Journal of Scientific & Technical Research, Vol.36(2)
Academic Unit
UMMG Dept of Radiation Oncology; Miller School of Medicine